Evaluation of the financial impact of ketorolac tromethamine therapy in hospitalized patients

Clinical Therapeutics

Volumn 18, Issue 1, 1996, Pages 197-211

  Burke, John P ^a,b   Pestotnik, Stanley L ^a   Classen, David C ^a   Lloyd, James F ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIPRURITIC AGENT; KETOROLAC TROMETAMOL; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CHOLECYSTECTOMY; COHORT ANALYSIS; COMPUTER; CONTROLLED STUDY; COST; FEMALE; HOSPITALIZATION; HUMAN; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORTHOPEDIC SURGERY; PHARMACOECONOMICS; POSTOPERATIVE PAIN; REGRESSION ANALYSIS; RESOURCE MANAGEMENT; RETROSPECTIVE STUDY; STATISTICAL MODEL; UNITED STATES; VOMITING;

EID: 0029819197     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80190-1     Document Type: Article

References (25)

1. Nash DB, Goldfarb NI. Exploring resource use in high-cost versus low-cost care: The pharmaceutical example. DRG Monit. 1987;4:1-8.
2. Sloan FA, Gordon GS, Cocks DL. Hospital drug formularies and use of hospital services. Med Care. 1993;31:851-867.
3. Bootman JL, Townsend RJ, McGhan WF. Introduction to pharmacoeconomics. In: Bootman JL, Townsend RJ, McGhan WF, eds. Principles of Pharmacoeconomics. Cincinnati: Harvey Whitney Books; 1991:3-17.
4. McDonald CJ, Tierney WM. Computerstored medical records. Their future role in medical practice. JAMA. 1988;259: 3433-3440.
5. Classen DC, Pestotnik SL, Evans RS, Burke JR Computerized surveillance of adverse drug events in hospitalized patients. JAMA. 1991;266:2847-2851.
6. Ketorolac tromethamine. Med Lett Drugs Ther. 1990;32(825):79-81.
7. Mayo M, Bynum L. Is ketorolac more cost effective? Am J Hosp Pharm. 1991;48: 2128-2129.
8. Pryor TA, Gardner RM, Clayton PD, et al. The HELP system. J Med Syst. 1983; 7:87-102.
9. Kuperman GJ, Gardner RM, Pryor TA. HELP: A Dynamic Hospital Information System. New York: Springer-Verlag; 1991.
10. Hulse RK, Clark SJ, Jackson JC, et al. Computerized medication monitoring system. Am J Hosp Pharm. 1976;33: 1061-1066.
11. Evans RS, Larsen RA, Burke JP, et al. Computer surveillance of hospital-acquired infections and antibiotic use. JAMA. 1986;256:1007-1011.
12. The LDS Hospital nurse acuity system. In: Nursing Care Manual. Salt Lake City, Utah: LDS Hospital; 1990.
13. Standard Cost Manager: User's Guide. Cleveland: Ernst and Whinney Inc, National Health Care Group; 1987.
14. Classen DC. Assessing the Effect of Adverse Hospital Events on the Cost of Hospitalization and Other Patient Outcomes. Salt Lake City, Utah: University of Utah; 1993. Thesis.
15. Evans RS, Classen DC, Stevens LE, et al. Using a hospital information system to assess the effects of adverse drug events. Proceedings from the Seventeenth Annual Symposium on Computer Applications in Medical Care, October 30-November 3, 1993, Washington, DC; 161-165.
16. Haley RW. Measuring the cost of nosocomial infections: Methods for estimating the economic burden on the hospital. Am J Med. 1991;91(Suppl 3b):145s-151s.
17. Haley RW. Cost benefit analysis of infection control programs. In: Bennett JV, Brachman PS, eds. Hospital Infections. 3rd ed. Boston: Little, Brown; 1992: 507-532.
18. The International Classification of Diseases. 9th revision. Clinical Modification (ICD 9 CM). 5th ed. New York: McGraw-Hill, Inc; 1996.
19. SPSS Statistical Package, Release 6.0.1. Chicago, I11: SPSS Inc; 1993.
20. Polissar L, Diehr P. Regression analysis in health services research: The use of dummy variables. Med Care. 1982;20: 959-966.
21. Detsky AS, Naghie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990;113:147-154.
22. Lee JT, Sanchez LA. Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature. Am J Hosp Pharm. 1991;48: 2622-2627.
23. Horwitz RI, Viscoli CM, Clemens JD, Sadock RT. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med. 1990;89: 630-638.
24. Sacks H, Chalmers TC, Smith H. Randomized versus historical control for clinical trials. Am J Med. 1982;72:233-240.
25. Spickler W. Ketorolac (Toradol): A new analgesic or an old NSAID? Can Med Assoc J. 1993;148:1693-1695.